Dr. Jeffrey H. Muler
Claim this profileProMedica Flower Hospital
Studies Cancer
Studies Bladder Cancer
10 reported clinical trials
27 drugs studied
Area of expertise
1Cancer
PD-L1 positive
Stage II
hCG positive
2Bladder Cancer
PD-L1 positive
hCG positive
Stage II
Affiliated Hospitals
Clinical Trials Jeffrey H. Muler is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Jeffrey H. Muler
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jeffrey H. Muler has experience with
- Nivolumab
- Carboplatin
- Ipilimumab
- Gemcitabine Hydrochloride
- Paclitaxel
- Pembrolizumab
Breakdown of trials Jeffrey H. Muler has run
Cancer
- Nivolumab + Ipilimumab for Rare Cancers
- Immunotherapy + Chemotherapy for Non-Small Cell Lung Cancer
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Bladder Cancer
- Nivolumab + Ipilimumab for Rare Cancers
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
- Blood Test and Immunotherapy for Bladder Cancer
Transitional Cell Carcinoma
- Nivolumab + Ipilimumab for Rare Cancers
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
- Blood Test and Immunotherapy for Bladder Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey H. Muler specialize in?
Jeffrey H. Muler focuses on Cancer and Bladder Cancer. In particular, much of their work with Cancer has involved PD-L1 positive patients, or patients who are Stage II.
Is Jeffrey H. Muler currently recruiting for clinical trials?
Yes, Jeffrey H. Muler is currently recruiting for 4 clinical trials in Sylvania Ohio. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey H. Muler has studied deeply?
Yes, Jeffrey H. Muler has studied treatments such as Nivolumab, Carboplatin, Ipilimumab.
What is the best way to schedule an appointment with Jeffrey H. Muler?
Apply for one of the trials that Jeffrey H. Muler is conducting.
What is the office address of Jeffrey H. Muler?
The office of Jeffrey H. Muler is located at: ProMedica Flower Hospital, Sylvania, Ohio 43560 United States. This is the address for their practice at the ProMedica Flower Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.